Form 8-K - Current report:
SEC Accession No. 0001493152-25-005559
Filing Date
2025-02-10
Accepted
2025-02-10 09:14:54
Documents
20
Period of Report
2025-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50281
2 ex1-1.htm EX-1.1 301447
3 ex4-1.htm EX-4.1 117520
4 ex5-1.htm EX-5.1 14852
5 ex99-1.htm EX-99.1 17306
6 ex99-2.htm EX-99.2 13921
7 ex5-1_001.jpg GRAPHIC 5763
  Complete submission text file 0001493152-25-005559.txt   849832

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE rnxt-20250210.xsd EX-101.SCH 3260
9 XBRL DEFINITION FILE rnxt-20250210_def.xml EX-101.DEF 26190
10 XBRL LABEL FILE rnxt-20250210_lab.xml EX-101.LAB 35952
11 XBRL PRESENTATION FILE rnxt-20250210_pre.xml EX-101.PRE 24848
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5193
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 25603907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)